4 research outputs found
The role of warmed intravenous fluid on intraoperative hypothermia and postoperative shivering during prolonged oral and maxillofacial surgery
Background: Under general anaesthesia, the core temperature may drop up to 6°C. Patients undergoing prolonged maxillofacial surgery frequently experience unintentional hypothermia that causes postanaesthetic shivering which is a common complication of anaesthesia that should be prevented. This study aimed to evaluate the role of warmed intravenous fluid in preventing intraoperative hypothermia and postoperative shivering.
Methods: Between January 2022 and December 2022, 322 patients with American Society of Anesthesiologists (ASA) physical status I, II and the age group of 18 to 45 years old scheduled for elective major oral and maxillofacial surgery were evaluated under the Department of Anaesthesiology in Dhaka Dental College and Hospital. The patients were grouped into Room Temperature Group and Warmed Fluid Group.
Results: 162 patients received warmed fluid, whereas 160 patients received fluid at room temperature. In Room Temperature Group, there were 89 male and 71 female patients, whereas Warmed Fluid group had 88 male and 74 female patients. At the end of the procedure, the basal core temperature was 36.7±0.2°C in the group receiving warmed fluid versus 35.9±0.2°C in the group receiving fluid at room temperature. The incidence of hypothermia (<36 °C) was much lower in Warmed Fluid Group (n=28, 17.28%) than Room Temperature Group (n=86, 53.75%). Shivering was more common in Room Temperature Group (n = 67, 41.86%) than in Warmed Fluid Group (n = 19, 11.73%) in the postanaesthetic care unit (PACU).
Conclusions: The results of this study suggested that intraoperative hypothermia and postoperative shivering are less common when warmed fluid is infused.
Â
Bioactive secondary metabolites from the endophytic fungus Chaetomium sp. isolated from Salvia officinalis growing in Morocco
This study reports the chemical investigation and cytotoxic activity of the secondary metabolites produced by the endophytic fungus Chaetomium sp. isolated from Salvia officinalis growing in Morocco. This plant was collected from the Beni-Mellal Mountain in Morocco and belongs to the Lamiaceae family and is named in Morocco “Salmia”. The endophytic fungus Chaetomium sp. was isolated from the tissues of the stem of this plant. The fungal strain was identified by PCR. The crude organic extract of the fungal strain was proven to be active when tested for cytotoxicity against L5178Y mouse lymphoma cells. Chemical investigation of the secondary metabolites showed that cochliodinol is the main component beside isocochliodinol. The structures of the isolated compounds were determined on the basis of NMR analysis (1H, 13C, COSY and HMBC) as well as by mass spectrometry using ESI (Electron Spray Ionisation) as source